LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways

Seung Woo Chung, Sang Mun Bae, Myungjin Lee, Taslim A. Al-Hilal, Chang Kyung Lee, Jeong Kon Kim, In San Kim, Sang Yoon Kim, Youngro Byun

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Fingerprint

Dive into the research topics of 'LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways'. Together they form a unique fingerprint.

Engineering & Materials Science

Medicine & Life Sciences

Chemical Compounds